Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Blockade in Total Hip Replacement Arthroplasty
NCT03369782Phase 4Withdrawn
- Sponsor
- AZ Maria Middelares
- Start
- Dec 2017
- Primary completion
- Apr 2018
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium, Sugammadex in postoperative pain, sponsored by AZ Maria Middelares. Planned start Dec 2017; status: withdrawn.
02
Drugs
rocuroniumSugammadex
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03369782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369782.